Cargando…

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects.

The optimal schedule for recombinant interleukin-2 (rIL-2) administration is unclear. Because the clinical and immunological effects of prolonged continuous exposure to rIL-2 are unknown, we have conducted a phase I study to assess the toxicity and feasibility of continuous low dose infusion of rIL-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlasveld, L. T., Rankin, E. M., Hekman, A., Rodenhuis, S., Beijnen, J. H., Hilton, A. M., Dubbelman, A. C., Vyth-Dreese, F. A., Melief, C. J.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1992
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977401/ https://www.ncbi.nlm.nih.gov/pubmed/1586602

Ejemplares similares

A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.
por: Vlasveld, L. T., et al.
Publicado: (1993)

Reply to the letter from Janssen et al
por: Vlasveld, L.T., et al.
Publicado: (1994)

Phase I and pharmacological study of sequential intravenous topotecan and oral etoposide.
por: Herben, V. M., et al.
Publicado: (1997)

Historical aspects of infectious diseases, part I
por: Cunha, Burke A.
Publicado: (2004)

Social Aspects of Psychiatry—Part I
por: Lewis, Aubrey
Publicado: (1951)

Single Intramammary Infusion of Recombinant Bovine Interleukin-8 at Dry-Off Induces the Prolonged Secretion of Leukocyte Elastase, Inflammatory Lactoferrin-Derived Peptides, and Interleukin-8 in Dairy Cows
por: Watanabe, Atsushi, et al.
Publicado: (2012)

Educational paper: Abusive Head Trauma Part I. Clinical aspects
por: Sieswerda-Hoogendoorn, Tessa, et al.
Publicado: (2011)

Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children
por: Haenecour, A, et al.
Publicado: (2015)

Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy.
por: Oliver, R. T., et al.
Publicado: (1989)

Child Abuse, Misdiagnosed by an Expertise Center: Part I—Medico-Social Aspects
por: Vlaming, Marianne, et al.
Publicado: (2023)

Recombinant Human Deoxyribonuclease I
por: Lazarus, Robert A., et al.
Publicado: (2019)

Postcolumn Infusion as a Quality Control Tool for LC-MS-Based Analysis
por: González, Oskar, et al.
Publicado: (2022)

Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma
por: Liu-Chittenden, Yi, et al.
Publicado: (2015)

Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - Part I()
por: dos Santos, Josemir Belo, et al.
Publicado: (2014)

Observations on Some Immunological Aspects of Leptospiral Infections: Part I
por: Gupta, B. M. Das
Publicado: (1939)

Macrophage-Dependent Interleukin-6-Production and Inhibition of I(K) Contributes to Acquired QT Prolongation in Lipotoxic Guinea Pig Heart
por: Chowdhury, Md. Kamrul Hasan, et al.
Publicado: (2021)

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial.
por: Gilleece, M. H., et al.
Publicado: (1992)

A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease.
por: Gottlieb, D. J., et al.
Publicado: (1989)

Aspects of differential geometry I
por: Gilkey, Peter, et al.
Publicado: (2015)

Modern Aspects of Appendicitis.—I
Publicado: (1893)

High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy
por: de Jonge, M E, et al.
Publicado: (2006)

Sustained exercise hyperemia during prolonged adenosine infusion in humans
por: Ranadive, Sushant M., et al.
Publicado: (2019)

Indigestion, Biliousness, and Gout in the Protean Aspects. Part I. Indigestion and Biliousness
Publicado: (1888)

Prolonged continuous infusion of low-dose rIL-2.
por: Janssen, R. A., et al.
Publicado: (1994)

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
por: Melief, Cornelis J. M., et al.
Publicado: (2017)

Should I stay or should I go? Fitness costs and benefits of prolonged parent–offspring and sibling–sibling associations in an Arctic-nesting goose population
por: Weegman, Mitch D., et al.
Publicado: (2016)

Ultrasound elastography in the head and neck. Part I. Basic principles and practical aspects
por: Bhatia, Kunwar S.S., et al.
Publicado: (2013)

Indigestion, Biliousness, and Gout in Its Protean Aspects. Part I: Indigestion and Biliousness
Publicado: (1882)

The Medico-Legal Aspects of Poisons—I
Publicado: (1909)

Studies in Phaeochromocytoma: I. Pathological Aspects
por: Symington, Thomas, et al.
Publicado: (1953)

An Unusual Case of Transient Diabetes Insipidus After Prolonged Vasopressin Infusion
por: Chang, Albert, et al.
Publicado: (2021)

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFNα in patients with metastatic melanoma
por: de Gast, G C, et al.
Publicado: (2003)

Dreaming: Part I
por: Macfarlane, A. W.
Publicado: (1891)

Part I Dictionary
por: Gunn, S. William A.
Publicado: (2012)

Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study.
por: Thatcher, N., et al.
Publicado: (1989)

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
por: Dercksen, M. W., et al.
Publicado: (1993)

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
por: Jansen, E P M, et al.
Publicado: (2007)

High Dose, Prolonged Epsilon Aminocaproic Acid Infusion, and Recombinant Factor VII for Massive Postoperative Retroperitoneal Hemorrhage following Splenectomy
por: Lee, Alex T., et al.
Publicado: (2016)

Phase I study of 21 days continuous infusion with vindesine.
por: de Vries, E. G., et al.
Publicado: (1989)

A Hazard Analysis of Class I Recalls of Infusion Pumps
por: Gao, Xuemei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1qk6h6lu1a5oqj8hbdav2a48bt